U.S. Provisional Patent Application 63/337,114, our docket FGPMXQ22BP, filed on May 1, 2022, is incorporated by reference in its entiriety, including diagrams, into the present patent application.
The following publications are incorporated by reference into the present disclosure, including their drawings:
The present invention relates to packaging systems for shipping, transport, handling, and logistics of temperature sensitive payloads such as, but not limited to, medicines, biologics, and food products, with improved reconfigurability for optional return shipping of the emptied packaging system.
A trend toward direct-to-patient specialty medication delivery has been growing for several years, which has only been accelerated by COVID-19 restrictions. These medications are often biologics and must be kept within strict temperature ranges. For specialty pharmacies this has meant purchasing and storing bulky, expensive and single-use packaging solutions cumbersome for both pharmacists and patients—and incurring increasing inbound and outbound freight costs, as well as negative environmental impact.
A packaging system for shipping temperature-sensitive payloads to an end-user which is reconfigurable for easy, efficient and cost-effective return shipping by the end-user.
The figures presented herein, when considered in light of this description, form a complete disclosure of one or more embodiments of the invention, wherein like reference numbers in the figures represent similar or same elements or steps.
The present inventor(s) have recognized that existing shipping methods, processes, and packages are insufficient for meeting the demands of the modern pharmacy and consumer, especially with respect to delivering temperature-sensitive products from a pharmacy, such as a retail store or a centralized prescription fulfillment center, to a patient, such as a residential address. Consumers (patients) are sensitive to the waste they observe in one-time-use product packaging, such as a non-reusable thermal boxes and non-reusable frozen packs. Shipping companies add a premium to large volume (three-dimensional displacement), low-weight shipments, such as a return shipments of empty cartons. And, pharmacies have limited space to store rigid, nesting containers and limited available cost overhead to absorb additional shipping cost for the weight of such containers.
Many of the medications specialty pharmacies dispense are biologics, which means the payloads must be kept within strict temperature ranges so they don't get too hot or too cold. This requirement is easy enough to meet when storing them onsite in refrigerators—but involving complicated logistics when sending out to patients, including the last leg of transit from the pharmacy to the end-user (consumer, patient).
For these reasons, and to meet these unfulfilled needs in the market, the present inventors have designed and tested for technical performance as well as for consumer acceptance a class of purpose-built shipping containers for temperature sensitive biologics. A proper cold transportation chain needs to consider a range of factors, including the climate and season of where medication is being dispensed as well as where it's going. It also needs to take into account unexpected supply chain disruptions like severe weather events or even a global pandemic that can slow delivery. The one or more example embodiments of the present invention can meet all of these requirements in a cost effective, environmentally senstive and consumer-accepting manner.
The containers of the present invention simplify direct-to-patient delivery of such temperature-senstive products. The various embodiments provide a range of easy-to-use cold chain solutions which eliminate the need for multiple or seasonal pack-outs. The packing systems can be pre-qualified to hold precise temperatures for specific payloads during transport, using standardized packing protocols, no matter what time of year or the destination, to save time and make training staff easier.
At least one advantage of some embodiments according to the present invention provides multipurpose solutions for optimum efficiency in which the packaging systems of the present invention are designed specifically to help specialty pharmacies streamline processes and cut costs to ship medications with any temperature maintenance profile from controlled room temperature (CRT) to refrigerated. At least one embodiment of the present invention has been performance qualification (PQ) tested to support Utilization Review Accreditation Commission (URAC) accreditation.
Specific Embodiment Examples. At least one prototype design according to the present invention has been fabricated, performance-verified in a laboratory environment, and field tested with a set of beta-test consumers using real logistics handling services. In particular, this at least one prototype design:
Designed for expedited transport of specialty pharmacy medication, the prototype packaging system delivers quality performance in a compact container. At least two example sizes (outer dimensions) allow for temperature-controlled shipping and delivery for up to 36 hours or up to 48 hours at refrigerated temperatures. The example embodiments are up to 75% smaller and 50% lighter than current specialty pharmacy logistics solutions, which can reduce shipping costs by as much as 50%. Additionally, since less storage space is needed—the specialty pharmacy operating environment becomes more efficient.
To maximize cost efficiencies further, the packaging system is qualified for universal, all-season packouts so pharmacies can perform PQ testing once a year. The standardized packaging system can be assembled in seconds, eliminating the need for staff retraining or operational adjustments during seasonal transitions. The packaging system is designed specifically for specialty pharmacy shipments, and is tested to ISTA 7D and 7E profiles.
Referring to
The following method of use, assembly and disassembly will also explain the components of the design of this example embodiment to illustrate the invention in detail. Other dimensions, sequences of materials, and configurations are available within the scope of the present invention.
Referring now to
Next, the outer carton 201 is assembled in an conventional manner, such as folding, unfolding, bending, taping, gluing, etc., to produce an interior space with one or more open top panels. One or more thin, high performance thermal insulation panels 202, 203 which are designed to pack flat when not in use (i.e., before or after shipping is completed) are prepared by bending a rectangular thermal insulation sheet at designated lines, such as scored lines, to yield a thermal liner which is proportioned and sized to fit as a liner in the interior volume of the carton 202 when assembled. This particular embodiment uses a two-component thermal liner which completely flattens into two rectangular sheets to reduce the size of the return-shipment package. When assembled, this particular embodiment has two U- or C-shaped components, as shown, which nest into each other to produce a fully enclosed thermal liner, which is easily inserted 204 into the assembled outer carton 201, as shown 205.
Referring now to
Referring now to
An example filled packaging system 500 according to this embodiment is shown in
The end-user (i.e., patient, consumer, etc.) can easily remove the return shipping materials, remove the payload, remove the thermal liner, flatten the thermal liner, and flatten the outer carton. Then, the flattened thermal liner and outer carton can be placed into the return shipping bag or box along with the gel packs, and the return shipping label, if provided, can be affixed to prepare the used packing system for compact, efficient and cost-effective return shipping to the pharmacy, wholesaler, supplier or distributor.
Laboratory and Field Testing Results. As an integral part of the development process for a packaging system such as the present invention, the inventors concluded that real-life or real-world testing would be required to validate and prove the performance of the designs beyond the controlled environment of laboratory tests. The following paragraphs summarize such tests and their results, which further enable the reader to understand the present invention and the one or more example embodiments disclosed herein. The invention is not limited to the one or more test scenarios described herein, however, as those ordinarily skilled in the art will readily recognize.
To validate the efficacy of the packout, a pilot study was conducted with patients of specialty pharmacies strategically selected for their different climates and geography. A total of 755 prototype packaging systems were distributed to eight specialty pharmacies across the United States. Over an eight-week period, pilot study participants used the prototype packaging system for their refrigerated medication shipments to patients in Rochester, NY; Buffalo, NY; Fort Wayne, IN; Los Angeles, CA; Vancouver, WA; Fort Myers, FL; and Hershey, PA. The results of the pilot study indicated that the thermal management requirements to protect the payload were met, and that consumers found the unpacking and return shipping process easy to perform and satisfying to complete.
Feedback was collected via an online survey, email and phone interviews. Among the feedback from the Specialty Pharmacy users were the following comments:
Among the feedback from the end users (patients, consumers, etc.) were the following comments:
Question 1: What did you like best about the MaxPlus PharmaPack SP?
Question 2: Ease of return and reuse: 100% of patients said they would send the shipper back to the specialty pharmacy if provided with a pre-printed return mailer bag.
Question 3: How is the size and weight of the protoytpe packaging system?
Question 4: Regarding ease of accessing the medication in package, 93% said they found the package easy to open.
Electronic Sensing and Tracking. Optionally, one or more on-board temperature sensors, data loggers, and/or wireless tracking modules may be provided with, on or in the packaging system to enable improved confidence in the shipping process and optimization for handling systems, route planning, etc. Such sensors can be wired, wireless (e.g., RFID, NFC, etc.), or a combination of both, and may be used to sense the payload temperature or the ambient temperature outside the package, or both.
Thermal Liner Materials. There are many thermal liner materials which are thin enough and light enough to meet the objectives of the present invention. In particular, the present inventors have used, tested and verified the performance of at least these materials:
Products Corporation of Rancho Dominguez, California, USA.
These insulation materials can be used separately or in combination with each other to produce the thermal lining of the present packaging system invention, as well as other equivalent materials from this and other manufaturers.
Conclusion. The terminology used herein is for the purpose of describing particular exemplary embodiments only and is not intended to be limiting of the invention. As used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof, unless specifically stated otherwise.
The corresponding structures, materials, acts, and equivalents of all means or step plus function elements in the claims below are intended to include any structure, material, or act for performing the function in combination with other claimed elements as specifically claimed. The description of the present invention has been presented for purposes of illustration and description, but is not intended to be exhaustive or limited to the invention in the form disclosed. Many modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the invention. The embodiment was chosen and described in order to best explain the principles of the invention and the practical application, and to enable others of ordinary skill in the art to understand the invention for various embodiments with various modifications as are suited to the particular use contemplated. The foregoing example embodiments do not define the extent or scope of the present invention, but instead are provided as illustrations of how to make and use at least one embodiment of the invention.
This non-provisional patent application claims benefit of the filing date of U.S. Provisional Patent Application 63/337,114, our docket FGPMXQ22BP, which was filed on May 1, 2022.
| Number | Date | Country | |
|---|---|---|---|
| 63337114 | May 2022 | US |